President Trump, who announced he tested positive for COVID-19 early Friday morning, was headed to Walter Reed National Military Medical Center in the late afternoon for tests and possibly treatment.
Bloomberg reported that Trump would be staying at Walter Reed for “the next few days,” citing a statement from the White House.
An earlier statement from White House physician Sean Conley, DO, said the president had received “a single 8 gram dose of Regeneron’s polyclonal antibody cocktail,” which was completed “without incident.”
Regeneron had released topline results for its investigational REGN-COV2 antibody cocktail on Tuesday: the phase I/II/III trial showed the drug “reduced viral load and the time to alleviate symptoms in non-hospitalized patients with COVID-19,” as well as showing positive trends towards reducing medical visits.
But the product has not received FDA approval emergency use authorization yet, making it truly investigational. Some physicians on Twitter were puzzled that the